The Dutch SME is an innnovate company that operates in the fields of artificial intelligence (AI), wearables, and brain research. As a Pathfinder beneficiary, this company has a strong track record in collaborative, multi-disciplinary projects. With a focus on developing technologies that leverage brain data for real-world applications. The company has extensive experience working with global partners across various sectors, including universities, research institutions, small and medium enterprises (SMEs), large corporations, and healthcare organizations.

The company specializes in creating advanced wearable devices that monitor brain activity and apply AI to interpret neural signals in real time. Their core expertise lies in developing solutions that can predict, manage and prevent neurological conditions, such as epilepsy, using non-invasive and invasive devices.

Areas of Expertise:
• AI-Driven Brain Signal Analysis: Developing advanced algorithms for analyzing brain signals to predict and prevent neurological events.
• Wearable Devices: Specializing in the design of compact, user-friendly wearable devices for real-time brain monitoring.
• Seizure Prediction: Leading research in the field of epilepsy, focusing on AI models that can predict seizures with high accuracy.
• Neurotech Innovation: Working on solutions that integrate neuroscience and AI to create practical applications for both clinical and personal use.

They seek for collaboration opportunities with universities, small and medium-sized enterprises (SMEs), large companies, and hospitals that are engaged in brain research. Specifically, they aim to build partnerships that can help, advance their research and development efforts in the following areas:

• Wearable Device Innovation
• Neurology and Clinical Partners
• Data Collection and Analysis
• Regulatory and Clinical Trials Expertise
Advantages and innovation
The Dutch SME s innovative device offers comprehensive seizure coverage, predicting both convulsive and non-convulsive seizures in real time. Many existing devices focus solely on convulsive seizures, leaving patients vulnerable to non-convulsive episodes, which can be equally dangerous and potentially life-threatening. Given that many patients experience both types of seizures, the ability to predict all seizure forms is essential for ensuring full patient protection.

The device provides real-time seizure prediction with immediate alerts, allowing timely interventions and significantly enhancing patient safety. Unlike traditional technologies that primarily focus on detection or monitoring, this device accurately predicts seizures before they happen. A key advantage of the AI system developed by the Dutch SME is that it is not a "black box"—it operates transparently and complies with regulatory requirements, ensuring it meets the highest standards for safety and efficacy.

In addition, the novel AI is versatile and can be applied to the prediction of other brain anomalies, such as migraines, multiple sclerosis (MS), Parkinson s, and Alzheimer s disease, further extending the potential of this groundbreaking technology beyond seizure management.
Technical Specification or Expertise Sought
Their device is ready for clinical validation and further improvements in compact-design development. The AI system is highly adaptable and can be implemented not only in other brain data sets but also in other non-invasive and invasive devices, expanding its use case across a wider range of applications in brain monitoring and neurological care.

Thet company is are also exploring collaborations to combine their prediction technology with seizure prevention mechanisms, such as pharmaceutical interventions or neurostimulation techniques, to further improve clinical outcomes for patients. This approach aims to not only predict but also prevent seizures, offering a more comprehensive solution for managing neurological conditions.